Frequently Asked Questions from Pharmacy Providers about Drug Enforcement Agency Numbers and National Provider Identifier
Wisconsin Medicaid has received many questions from pharmacy
providers regarding 2003 Wisconsin Act 272 and its impact on Drug
Enforcement Agency numbers for the prescribing provider ID on claims and
prior authorizations. The following details these inquiries and the
appropriate responses.
Posted 5/30/08
|
Q. |
What does 2003 Wisconsin Act 272 mandate? |
A. |
Effective May 23, 2008, 2003 Wisconsin Act 272 mandates that providers may not disclose a practitioner’s federal registration number without consent. Under this act, prescribing providers may prohibit their Drug Enforcement Agency (DEA) number to be indicated on claims or prior authorizations (PAs). |
|
Q. |
How does Act 272 affect claims and prior authorizations? |
A. |
2003 Wisconsin Act 272 means that a DEA number cannot be required on claims and PAs. |
|
Q. |
How can claims and prior authorizations be submitted if the billing provider is unable to obtain the NPI and does not have consent to use the DEA number from the prescribing provider? |
A. |
The billing provider is required to adhere to the requirements of
2003 Wisconsin Act 272. If the billing provider is unable to obtain
the prescriber’s NPI or permission to use the prescriber’s DEA
number after a reasonable effort, then a “default” DEA number or the
pharmacy’s NPI (electronic claims only) may be submitted on the
claim or PA for successful processing. |
|
Q. |
How does Act 272 affect National Council for Prescription Drug Programs Version 5.1 transactions? |
A. |
Effective May 19, 2008, BadgerCare Plus accepts an NPI or a DEA
number for the prescriber ID on National Council for Prescription
Drug Programs Version 5.1 (NCPDP 5.1) transactions. |
|
Q. |
What is an appropriate default DEA number? |
A. |
If the prescriber’s DEA number is not obtained after a reasonable effort, there are two default DEA number options:
Providers who regularly and systematically use DEA numbers may be audited. For claims submitted through a software company, providers should check to ensure that a default DEA is not being automatically applied to claims in lieu of a valid DEA number. |
|
Q. |
Are there circumstances in which a default DEA number is not acceptable? |
A. |
Default DEA numbers will not be accepted on claims for controlled substances. State and federal regulations prohibit the use of default DEA numbers on prescriptions for controlled substances. |
|
Q. |
What issues may incur from using a default DEA number in lieu of the prescriber’s valid DEA number? |
A. |
Although it is acceptable for a billing provider to
indicate a default DEA number on claims and PAs, providers should be
aware that for Drug Utilization Review (DUR), targeted
interventions, lock-ins, and audits, the valid DEA number for the
prescriber yields useful information that will not be available when
substituting a default DEA. |
|
Q. |
How does Act 272 affect Specialized Transmission Approval Technology-Prior Authorizations? |
A. |
It is important to note that Specialized
Transmission Approval Technology-Prior Authorizations (STAT-PAs)
will not accept an NPI until the implementation of ForwardHealth
interChange in October 2008. If a provider enters a STAT-PA with an
NPI prior to implementation, the PA will be returned. |
|
Q. |
How does Act 272 affect paper Compound Drug claims and Noncompound Drug claims? |
A. |
It is important to note that paper Compound Drug
Claim form, HCF 13073 (06/03), and Noncompound Drug Claim form, HCF
13072 (06/03), will not accept an NPI until the implementation of
ForwardHealth interChange in October 2008. If a paper claim is
submitted with an NPI prior to implementation, the claim will be
denied. |
|
Q. |
How does Act 272 affect paper PAs and attachments? |
A. |
It is important to note that paper PAs will not
accept an NPI until the implementation of ForwardHealth interChange
in October 2008. If a paper PA is submitted with an NPI prior to
implementation, the PA will be denied. |
Back to NPI Home

